Trial Details

ACTIVE_NOT_RECRUITING
Basic Information
Clinical ID c975
Identifier NCT02721719
Trial Title The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions -
Participant Information
Sponsor University of British Columbia
City Vancouver
Country/Region Canada
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2025-05-16
Primary Completion Date 2025-12-23
Completion Date 2025-12-24